The current generic protocol proposes a uniform approach for active invasive pneumococcal disease (IPD) surveillance in children and enhanced surveillance in other age groups.
This external quality assessment (EQA) to assess the ability of national reference laboratories from EU/EEA Member States to correctly perform laboratory serodiagnostic tests for pertussis was a collaborative study organised from February to April 2016.